MSMichael Schoenbaum

Michael Schoenbaum

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Michael Schoenbaum has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Exploratory Evidence on the Market for Effective Depression Care in Pittsburgh

    by Michael Schoenbaum, Kelly Kelleher, Judith R. Lave, Stephanie Green, Donna Keyser, Harold Pincus

    Despite the existence of effective and relatively cost-effective depression treatments, many depressed patients do not receive appropriate care. The authors assessed opportunities for increasing the rate of effective depression treatment by investigating the market for such treatment in the Pittsburgh area. A conceptual framework was developed to evaluate the market for effective depression care. On the basis of the conceptual framework, interviews were conducted with representatives from seven large employers, two medical health insurance carriers, two behavioral health insurance carriers, four primary care providers, and four behavioral health care providers. Respondents were asked to assess the barriers to and opportunities for increasing the rates of depression treatment from their perspectives. The findings suggest that there is currently little demand among purchasers for improving depression care and little interest among insurers and providers for improving care in the absence of purchaser demand. Even stakeholders who identified depression as an important problem could not come to a consensus about who should be responsible for addressing the problem. Employers reported that they look primarily to their vendors to initiate quality improvement efforts, whereas insurers reported that such improvement efforts were more likely to occur if they were initiated by employers who purchase their health plans; providers, in turn, reported feeling powerless to initiate change. The absence of a clear locus of responsibility for improving depression care lends considerable inertia to the status quo. Because the currently low treatment rates are likely to be socially inefficient, researchers and policy makers should consider strategies to help overcome this inertia.


  • Open Access

    Cost-effectiveness of Practice-Initiated Quality Improvement for Depression

    by Michael Schoenbaum, Jürgen Unützer, Cathy Sherbourne, Naihua Duan, Lisa V. Rubenstein, Jeanne Miranda, Lisa S. Meredith, Maureen F. Carney, Kenneth Wells

    Depression is common among primary care patients and practice guidelines are available, yet quality of care and outcomes remain poor.1-10 Improving quality of care for depression in primary care could potentially increase well-being for patients, their families, and society at large.11,12


  • Costs and Utilization of Substance Abuse Care in a Privately Insured Population Under Managed Care

    by Michael Schoenbaum, Weiying Zhang, Roland Sturm

    Cost and utilization patterns of substance abuse and mental health treatment under private, employer-sponsored, managed behavioral health care plans were examined. Data were from claims made in 1995 in 93 behavioral health care plans covering 617,133 members. Rates of use of mental health and substance abuse care were determined, as were payments by insurers and patients for the two types of care. Means were calculated per plan member and per user of either of these service types. Approximately .3 percent of plan members used any substance abuse services; 5.2 percent used mental health services. However, among substance abuse patients, average costs were more than twice as high as average costs for mental health patients. For substance abuse treatment, the annual cost per user was $2,188, compared with $979 for users of mental health care. Annual per-member costs were $6.51 for substance abuse treatment and $50.08 for mental health care. Higher costs for substance abuse treatment reflected greater rates of use of both inpatient and intensive outpatient treatment. Overall, substance abuse costs represented 13 percent of insurance payments for behavioral health care and perhaps .4 percent of the cost of health insurance overall. Substance abuse coverage accounts for a small fraction of insurance payments for behavioral health coverage and a very small fraction of insurance payments for both physical and behavioral health care.